Brief: Pharmaxis Plans To Commence Trial Of Combination Therapy In 2023
12/04/2023 01:53
April 12 (Reuters) - Pharmaxis Ltd PXS.AX :
* PLANS TO COMMENCE TRIAL OF COMBINATION THERAPY WITH
MYELOFIBROSIS STANDARD OF CARE TREATMENT IN CY 2023
Source text for Eikon: ID:nASX4JWN9s
Further company coverage: PXS.AX
((Reuters.Briefs@thomsonreuters.com;))